'Sperm and germ'-fighting contraceptive enters trials

rm and germs, it must do so without hurting the friendly bacteria in a healthy vagina, like the lactobacilli, he explains. Also, it mustnt smell bad or taste bad or stain the sheets. And most importantly, it mustnt irritate sensitive vaginal tissues. BufferGel has met those standards both in animal trials and in extensive clinical safety trials, according to Cone.

For the new contraceptive efficacy trial, researchers at 10 sites in the United States are enrolling 1,000 women. Participants must be in a sexually active and monogamous relationship and at low risk for infection by sexually transmitted diseases. They must agree not to use other forms of contraception beyond that supplied by the study, and be willing to risk getting pregnant. Study participants will use a diaphragm with either BufferGel or a conventional spermicide.

In this trial, we want to achieve the highest possible level of protection, says Thomas Moench, medical director for ReProtect LLC. Were including a diaphragm because it places a discrete physical barrier over the cervix, significantly enhancing the protective actions of contraceptive microbicides.

Moench, formerly an assistant professor of infectious diseases at the Johns Hopkins Medical Institutions, originally created BufferGel with Cone. Hopkins and ReProtect LLC are developing BufferGel through a cooperative research agreement.

Researchers are also currently planning a larger trial to test BufferGels ability to block transmission of HIV and genital herpes. The trial is scheduled to take place through NIHs HIV Prevention Trials Network next year.


Contact: Michael Purdy
Johns Hopkins University

Page: 1 2

Related biology news :

1. Synthetic hormone used in contraceptives and HRT produces negative effects in monkey studies
2. UT Southwestern researchers discovery may lead to gene targets for new form of contraceptive
3. Oral contraceptives increase C-reactive protein, an infIammatory biomarker
4. The contraceptive plague
5. Newly found estrogen role in males might lead to contraceptive for men
6. New study shows oral contraceptive may be effective in treating severe form of premenstrual syndrome
7. Berlex Laboratories announces FDA approval of YASMIN (R), new oral contraceptive with unique progestin
8. Study suggests newer oral contraceptives may be less harmful for women smokers
9. NHGRI launches Centers for Excellence in Ethical, Legal, and Social Implications Research
10. Images reveal how rotavirus - leading cause of diarrhea - enters cells
11. Proteomic research centers target bioterrorism agents, infectious diseases

Post Your Comments:
TAG: Sperm and germ fighting contraceptive enters trials

(Date:9/10/2015)... , Sept. 10, 2015 This report provides ... technology products today, and emerging sensor types that will ... through the peak of the wearable technology hype curve ... to disillusionment. The common feature with all of them ... enabler for their most useful functions. Sensors collect data ...
(Date:9/9/2015)... Sept. 9, 2015  NuData Security announced today ... milestones, furthering the company,s commitment to protecting organizations ... NuData Security,s online fraud detection solution, ... growth cycle. The product combines continual analysis and ... user behavior from fraudulent behavior, allowing the company ...
(Date:9/2/2015)... California , September 2, 2015 ... the security purpose implied in a system which ... geometry, voice, signature, iris, vein, DNA and finger ... has forced to develop such system which provides ... username, password, PIN, Patterns and tokens are vulnerable ...
Breaking Biology News(10 mins):Wearable Sensors 2015-2025: Market Forecasts, Technologies, Players 2NuData Security Achieves Significant Milestones, Furthers Commitment to Providing Unparalleled Online Fraud Detection 2Biometrics Technology Market is Expected to Reach $13.8 Billion by 2015: Hexa Research Inc. 2Biometrics Technology Market is Expected to Reach $13.8 Billion by 2015: Hexa Research Inc. 3Biometrics Technology Market is Expected to Reach $13.8 Billion by 2015: Hexa Research Inc. 4
(Date:10/1/2015)... TORONTO , Oct. 1, 2015 Generex ... the issuance of a white paper on the use ... between Generex and CannScience Innovations Inc. ( www.cannsci.com ) ... delivery of cannabinoids and cannabinoid-derived formulations into the human ... the mouth). The white paper is authored ...
(Date:10/1/2015)... , Oct. 1, 2015 ... (SCRS), the global trade organization fully ... research sites, today announced a two-year relationship ... that provides a broad-range of expertise-based contract ... and services to the worldwide pharmaceutical, biotechnology ...
(Date:10/1/2015)... 1, 2015  xG Health Solutions, a leading ... a new platform for communication and collaboration with ... systems and health plans improve the quality and ... Health solutions, products and educational resources. ... as clinicians, we know the process of re-engineering ...
(Date:10/1/2015)...   Decision Resources Group finds that ... juvenile idiopathic arthritis (JIA) to guide therapeutic selection ... patients afflicted with this rare immune disorder. Such ... complex set of disorders composed of multiple subtypes—as ... approaches based on the growing repertoire of anti-inflammatory ...
Breaking Biology Technology:Generex Announces Issuance of Buccal Cannabis White Paper 2Generex Announces Issuance of Buccal Cannabis White Paper 3Generex Announces Issuance of Buccal Cannabis White Paper 4Society for Clinical Research Sites Welcomes PAREXEL as New Global Impact Partner 2xG Health Solutions Launches New Platform for Hospitals, Clinics and Health Plans 2Lack of Biomarkers to Guide Treatment Selection and Improve Patient Outcomes Are Key Unmet Needs in the Juvenile Idiopathic Arthritis Market 2Lack of Biomarkers to Guide Treatment Selection and Improve Patient Outcomes Are Key Unmet Needs in the Juvenile Idiopathic Arthritis Market 3
Cached News: